ArticleFrontiers in oncology2022

Tumor-specific T cell-mediated upregulation of PD-L1 in myelodysplastic syndrome cells does not affect T-cell killing.

Valentina Ferrari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.